Use of Erythropoiesis Stimulating Agents (ESAs) in Patients Receiving Myelosuppressive Chemotherapy in Europe and the UK (20190404)

22/11/2022
07/10/2025
EU PAS number:
EUPAS49757
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol-Published Amendment darbepoetin alfa 20190404 4 redacted

English (742.8 KB - PDF) View document
Updated protocol

Protocol-Published Amendment darbepoetin alfa 20190404 6.pdf

First published: 26/08/2024
English (791.03 KB - PDF) View document
Study results
Study results

20190404 ORSR.pdf

English (766.14 KB - PDF) View document
Study report
Other information